Design of the Brazilian BCG-REVAC trial against tuberculosis: A large, simple randomized community trial to evaluate the impact on tuberculosis of BCG revaccination at school age

Controlled Clinical Trials

Volumn 23, Issue 5, 2002, Pages 540-553

  Barreto, Mauricio L ^a   Rodrigues, Laura C ^b   Cunha, Sergio S ^a   Pereira, Susan ^a   Hijjar, Miguel A ^c   Ichihara, Maria Yury ^a   De Brito, Silvana C ^a   Dourado, Ines ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c MINISTÉRIO DA SAÚDE   (Brazil)

Author keywords

Bacillus Calmette Guerin; BCG; Brazil; Cluster randomization; Protective effect; Randomized clinical trial; Revaccination; Tuberculosis

Indexed keywords

BCG VACCINE;

ADOLESCENT; ADULT; BCG VACCINATION; BRAZIL; CHILDHOOD; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DEVELOPING COUNTRY; DRUG EFFICACY; EDUCATION; EVALUATION; FOLLOW UP; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MAJOR CLINICAL STUDY; METHODOLOGY; MORBIDITY; PATIENT INFORMATION; PATIENT SELECTION; POLICY; POPULATION; PROTECTION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REVACCINATION; REVIEW; SCHOOL CHILD; TUBERCULOSIS; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

EID: 0036775737     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(02)00216-7     Document Type: Article

References (18)

1. Bleed D., Dye C., Raviglione M.C. Dynamics and control of the global tuberculosis epidemic. Curr Opin Pulm Med. 6(3):2000;174-179.
2. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement. Global burden of tuberculosis. estimated incidence, prevalence, and mortality by country WHO Global Surveillance and Monitoring Project. JAMA. 18:1999;677-686.
3. Pilheu J.A. Tuberculosis 2000. problems and solutions Int J Tuberc Lung Dis. 2(9):1998;696-703.
4. Fine P.E.M., Carneiro I.A.M., Milstein J.B., Clemens C.J. Issues relating to the use of BCG in immunization programmes. discussion document:1999;Geneva, WHO, Dept. of Vaccine and Biologicals.
5. Fine P.E.M., Rodrigues L.C. Vaccination against mycobacterial diseases. Lancet. 332:1990;1016-1020.
6. Rodrigues L.C., Diwan V.K., Wheeler J.G. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis. a meta-analysis Int J Epidemiol. 22(6):1993;1154-1158.
7. Wunsch Filho V., de Castilho E.A., Rodrigues L.C., Huttly S.R. Effectiveness of BCG vaccination against tuberculous meningitis. a case-control study in Sao Paulo, Brazil Bull World Health Organ. 68(1):1990;69-74.
8. Carmargos P.A., Guimaraes M.D., Antunes C.M. Risk assessment for acquiring meningitis tuberculosis among children not vaccinated with BCG. a case-control study Int J Epidemiol. 17(1):1988;193-197.
9. Nascimento-Costa M.C., Andrade-Mota E.L., Silva-Pinto L.L. Protective effect of BCG against tuberculous meningitis. Bol Oficina Sanit Panam. 110(1):1991;26-32.
10. Ministerio de Saude [Brazil]. Programa Nacional de Controle da Tuberculosis: diretrizes para elaboracao do plano de acao emergenicial. FUNASA, Brasilia, 1994.
11. Sterne A.J., Rodrigues L.C., Guedes I.N. Does the efficacy of BCG decline with time since vaccination? Int J Tuberc Lung Dis. 2(3):1998;200-207.
12. Anonymous. Global programme on tuberculosis and global programme on vaccines. Statement on BCG revaccination for the prevention of tuberculosis. Weekly Epidemiological Record. 70:1995;229-231.
13. Karonga Prevention Trial. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet. 348(9019):1996;17-24.
14. Ponnighaus J.M., Fine P.E., Sterne J.A.et al. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet. 339(8794):1992;636-639.
15. Trnka L., Dankova D., Zitova J.et al. Survey of BCG vaccination policy in Europe. 1994-96 Bull World Health Organ. 76(1):1998;85-91.
16. Clemens J., Brenner R., Rao M., Tafari N., Lowe C. Evaluating new vaccines for developing countries. Efficacy or effectiveness? JAMA. 275(5):1996;390-397.
17. Smith P.G. Retrospective assessment of the effectiveness of BCG vaccination against tuberculosis using the case-control method. Tubercle. 63(1):1982;23-35.
18. Pereira S.M., Dourado I., Berreto M.L.et al. Sensitivity and specificity of BCG scar as an indicator of neonatal BCG vaccination. Int J Tuber Lung Dis. 5(11):2001;1067-1070.